Shirley Huang

PharmD, MS

Manager, evidence institute

Chapel Hill, NC

Theta represents the unknown measure of an angle. Angles help give perspective to seemingly constant variables. I strive to view the evolving healthcare landscape from different standpoints to anticipate what evidence is needed to deliver innovative medicines to patients. Angles also create balance and beauty, which I hope to find and deliver in my work.

BIOGRAPHY​

As a member of the Evidence Institute team, Shirley focuses on preparing high-quality evidence-based analyses and communicating insights to a wide variety of stakeholders. Prior to joining AESARA, Shirley completed a Clinical Health Outcomes Fellowship with GlaxoSmithKline (GSK) and the University of North Carolina (UNC) School of Pharmacy. At GSK, she supported the generation of evidence for GSK’s immunology portfolio. Shirley has experience in large healthcare claims database analyses, economic modelling, and targeted literature reviews.

Shirley has a doctorate in Pharmacy from the University of Illinois at Chicago College of Pharmacy and a master’s degree in Clinical Research from the UNC Gillings School of Global Public Health.

Key Achievements

  • Semi-finalist for Best General Poster Research Presentation Award
    ISPOR 24th Annual International Meeting 2019
    “Cost-Effectiveness of Web-Based Depression Programs for Adolescents”

  • Semi-finalist for Best General Poster Research Presentation Award
    ISPOR 23rd Annual International Meeting 2018
    “Long-Term Cost-Effectiveness of Valbenazine and Deutetrabenazine For Tardive Dyskinesia”

Key Publications

  • Huang SP, McKinzie CJ, Tak CR. Cost-effectiveness of implementing routine hearing screening using a tablet audiometer for pediatric cystic fibrosis patients receiving high-dose aminoglycosides. Journal of Managed Care and Specialty Pharmacy. 2021;27(2):1-8.

  • Bogart M, Germain G, Huang SP, Ismaila AS, Jung Y, Laberte, F, MacKnight S, Duh MS. Benefit of prompt vs delayed initiation of single-inhaler triple therapy on exacerbations and readmissions among patients with chronic obstructive pulmonary disease in a commercially insured US population.  Accepted to the American Thoracic Society (ATS) International Conference 2021.

  • Huang SP, Wang MJ, Dersarkissian M, Gu YM, Benson J, Jensen V, Duh MS, Bell CF. Healthcare Costs, Resource Utilization, and Adverse Events Associated with Long-term Oral Corticosteroid Use in Patients with Systemic Lupus Erythematous in the United States. Presented at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 26th Annual International Meeting 2021.

  • Huang SP, Li X, Nguyen J, Robinson J, Hogan SL, Kumar VD, Thorpe CT. The clinical and economic burden in the one-year pre-diagnosis period of ANCA-associated vasculitis patients in the Medicare population. Presented at American College of Rheumatology (ACR) Annual Meeting 2020. Virtual. 
    Bell CF, Wu B, Xie B, Huang SP, Chastek B, Rubin B, Von Felt J, Bryant G. Burden of illness of lupus nephritis in patients with Systemic Lupus Erythematosus. Presented at American Society of Nephrology (ASN) – Kidney Week 2020. Virtual.

  • Zhang KH, Huang SP, Touchette DR, Marko-Holguin M, Van Voorhees B. Cost-Effectiveness of Web-Based Depression Programs for Adolescents. Presented at International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 24th Annual International Meeting 2019. New Orleans, LA.

  • Huang SP, Fraidenburg D, Anguiano R. Characterizing the Accessibility and Burdens in the Medications in the Treatment of Pulmonary Arterial Hypertension. Presented at the American Thoracic Society (ATS) International Conference 2019. Dallas, TX.

  • Harrigan KM, Walton SM, Huang SP, Kumar VM, Chapman RH, Atlas SJ, Agboola FO, Ollendorf DA, Touchette DR. Long-Term Cost-Effectiveness of Valbenazine and Deutetrabenazine For Tardive Dyskinesia. Presented at International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting 2018. Baltimore, MD.

Connect

Areas of Expertise

  • Real-World Evidence

  • Epidemiology & Data

  • Biopharmaceuticals

  • Economic modelling

  • Targeted literature reviews

Education

  • Master of Science in Clinical Research, Epidemiology, UNC Gillings School of Global Public Health, NC

  • Doctor of Pharmacy, University of Illinois at Chicago, IL

  • Bachelor of Science in Biology
    Bachelor of Arts in Economics, Emory University, GA